Related Experiment Videos
[Experimental therapeutic modalities for retinitis pigmentosa]
1Department of Ophthalmology, Hadassah-Hebrew University Hospital and Medical School, Jerusalem.
Harefuah
|June 12, 2004
Summary
Novel treatments for Retinitis Pigmentosa (RP) are emerging. This review covers gene therapy, stem cells, and retinal prostheses, offering hope for vision restoration in RP patients.
Area of Science:
- Ophthalmology
- Genetics
- Regenerative Medicine
Context:
- Retinitis Pigmentosa (RP) is a group of inherited retinal diseases causing degeneration and blindness.
- Recent advances in understanding RP pathogenesis and molecular biology have spurred therapeutic development.
Purpose:
- To review emerging therapeutic strategies for Retinitis Pigmentosa.
- To discuss gene therapy, neurotrophic factors, nutritional modifications, cell transplantation, and retinal prostheses.
Summary:
- This second part of the review details retinal and retinal pigment epithelium transplantation.
- It also covers stem cell therapy for replacing degenerating retinal cells.
- Development of electro-optical retinal prostheses is also described.
Impact:
- Experimental progress offers hope for slowing RP progression.
- Potential for partial restoration of visual function in RP patients.
- Advances in RP treatment strategies are rapidly evolving.